BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2386591)

  • 1. The platelet count in Kawasaki syndrome.
    Barton LL; Friedman AD
    Am J Dis Child; 1990 Jun; 144(6):617-8. PubMed ID: 2386591
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatty acid composition of platelet phospholipids and plasma total lipids in Kawasaki disease.
    Hidaka T; Furuno H; Sugiyama M; Kagiyama A; Ogura R; Yamashita F; Kato H; Eto Y; Inokuchi T
    Acta Paediatr Jpn; 1988 Jun; 30(3):294-8. PubMed ID: 3150213
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the platelet mucocutaneous lymph node syndrome (MCLS)--platelet function--].
    Mukaiyama H
    Rinsho Ketsueki; 1982 Apr; 23(4):449-58. PubMed ID: 6215508
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of blood neuraminidase activities and free sialic acid, with special reference to the fluctuations in Kawasaki disease].
    Yamada K; Meguro T; Miyaji Y; Mori N; Inagaki M; Tomita K; Taki M; Miura T; Saito N
    Rinsho Byori; 1983 Mar; Suppl 54():200-2. PubMed ID: 6887578
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelets in Kawasaki patients: two different populations with different mitochondrial functions.
    Pietraforte D; Gambardella L; Marchesi A; Tarissi de Jacobis I; Villani A; Del Principe D; Malorni W; Straface E
    Int J Cardiol; 2014 Mar; 172(2):526-8. PubMed ID: 24491862
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet tocopherol levels in mucocutaneous lymph node syndrome (MCLS: Kawasaki disease).
    Yaoi K; Yamashiro K; Nakagawa S; Mino M
    J Nutr Sci Vitaminol (Tokyo); 1983 Jun; 29(3):261-70. PubMed ID: 6619990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease.
    Kawamura Y; Takeshita S; Kanai T; Yoshida Y; Nonoyama S
    J Pediatr; 2016 Nov; 178():281-284.e1. PubMed ID: 27526622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent.
    Yamada K; Fukumoto T; Shinkai A; Shirahata A; Meguro T
    Nihon Ketsueki Gakkai Zasshi; 1978 Aug; 41(4):791-802. PubMed ID: 716791
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis.
    Levin M; Holland PC; Nokes TJ; Novelli V; Mola M; Levinsky RJ; Dillon MJ; Barratt TM; Marshall WC
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1456-60. PubMed ID: 3922532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohyperkalaemia in Kawasaki disease.
    Robson WL; Leung AK; Kabani AM; Fick GH
    Eur J Pediatr; 1993 Apr; 152(4):379-80. PubMed ID: 8482298
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between mean platelet volume-to-lymphocyte ratio and coronary artery abnormalities in Kawasaki disease.
    Bozlu G; Karpuz D; Hallioglu O; Unal S; Kuyucu N
    Cardiol Young; 2018 Jun; 28(6):832-836. PubMed ID: 29656728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms.
    Burns JC; Glode MP; Clarke SH; Wiggins J; Hathaway WE
    J Pediatr; 1984 Aug; 105(2):206-11. PubMed ID: 6235335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease.
    Liu R; Gao F; Huo J; Yi Q
    Platelets; 2012; 23(1):11-6. PubMed ID: 21675937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kawasaki mucocutaneous lymph node syndrome. 3 cases].
    Estavoyer JM; Boichard D; Folschweiller B; Baufle GH; Debrand J; Perat R
    Nouv Presse Med; 1979 Sep; 8(36):2908. PubMed ID: 493102
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum thrombopoietin levels in Kawasaki disease.
    Miura N; Terai M; Meng YG; Sato T; Niimi H
    Br J Haematol; 1998 Feb; 100(2):387-8. PubMed ID: 9488632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation abnormalities in Kawasaki disease.
    Yamada K; Shirahata A; Inagaki M
    Prog Clin Biol Res; 1987; 250():239-50. PubMed ID: 3321078
    [No Abstract]   [Full Text] [Related]  

  • 17. Extreme thrombocytosis predicts Kawasaki disease in infants.
    Nigrovic LE; Nigrovic PA; Harper MB; Chiang VW
    Clin Pediatr (Phila); 2006 Jun; 45(5):446-52. PubMed ID: 16891278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient thrombocytopenia with large platelets in Kawasaki disease.
    Asano T; Sudoh M; Watanabe M; Fujino O
    Pediatr Hematol Oncol; 2007; 24(7):551-4. PubMed ID: 17786792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease mimicking retropharyngeal abscess.
    Pontell J; Rosenfeld RM; Kohn B
    Otolaryngol Head Neck Surg; 1994 Apr; 110(4):428-30. PubMed ID: 8170688
    [No Abstract]   [Full Text] [Related]  

  • 20. Value of degenerative change in neutrophils as a diagnostic test for Kawasaki syndrome.
    Rowe PC; Quinlan A; Luke BK
    J Pediatr; 1991 Sep; 119(3):370-4. PubMed ID: 1880648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.